# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-26-040893
Filing Date
2026-04-08
Accepted
2026-04-08 16:06:53
Documents
31
Period of Report
2026-04-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | tm2611275d2_6k.htm | 6-K | 12922
2 | EXHIBIT 99.1 | tm2611275d2_ex99-1.htm | EX-99.1 | 48246
3 | EXHIBIT 99.2 | tm2611275d2_ex99-2.htm | EX-99.2 | 18753
4 | GRAPHIC | tm2611275d2_ex99-1img001.jpg | GRAPHIC | 177156
5 | GRAPHIC | tm2611275d2_ex99-1img002.jpg | GRAPHIC | 110424
6 | GRAPHIC | tm2611275d2_ex99-1img003.jpg | GRAPHIC | 310264
7 | GRAPHIC | tm2611275d2_ex99-1img004.jpg | GRAPHIC | 119591
8 | GRAPHIC | tm2611275d2_ex99-1img005.jpg | GRAPHIC | 137633
9 | GRAPHIC | tm2611275d2_ex99-1img006.jpg | GRAPHIC | 135295
10 | GRAPHIC | tm2611275d2_ex99-1img007.jpg | GRAPHIC | 150769
11 | GRAPHIC | tm2611275d2_ex99-1img008.jpg | GRAPHIC | 135041
12 | GRAPHIC | tm2611275d2_ex99-1img009.jpg | GRAPHIC | 116512
13 | GRAPHIC | tm2611275d2_ex99-1img010.jpg | GRAPHIC | 158304
14 | GRAPHIC | tm2611275d2_ex99-1img011.jpg | GRAPHIC | 184036
15 | GRAPHIC | tm2611275d2_ex99-1img012.jpg | GRAPHIC | 120939
16 | GRAPHIC | tm2611275d2_ex99-1img013.jpg | GRAPHIC | 151716
17 | GRAPHIC | tm2611275d2_ex99-1img014.jpg | GRAPHIC | 138314
18 | GRAPHIC | tm2611275d2_ex99-1img015.jpg | GRAPHIC | 144122
19 | GRAPHIC | tm2611275d2_ex99-1img016.jpg | GRAPHIC | 123172
20 | GRAPHIC | tm2611275d2_ex99-1img017.jpg | GRAPHIC | 178179
21 | GRAPHIC | tm2611275d2_ex99-1img018.jpg | GRAPHIC | 105554
22 | GRAPHIC | tm2611275d2_ex99-1img019.jpg | GRAPHIC | 144708
23 | GRAPHIC | tm2611275d2_ex99-1img020.jpg | GRAPHIC | 139907
24 | GRAPHIC | tm2611275d2_ex99-1img021.jpg | GRAPHIC | 165896
25 | GRAPHIC | tm2611275d2_ex99-1img022.jpg | GRAPHIC | 135937
26 | GRAPHIC | tm2611275d2_ex99-1img023.jpg | GRAPHIC | 126263
27 | GRAPHIC | tm2611275d2_ex99-1img024.jpg | GRAPHIC | 173769
28 | GRAPHIC | tm2611275d2_ex99-1img025.jpg | GRAPHIC | 182470
29 | GRAPHIC | tm2611275d2_ex99-1img026.jpg | GRAPHIC | 112682
30 | GRAPHIC | tm2611275d2_ex99-1img027.jpg | GRAPHIC | 114931
31 | GRAPHIC | tm2611275d2_ex99-1img028.jpg | GRAPHIC | 78464
| Complete submission text file | 0001104659-26-040893.txt |  | 5672760

Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 26848173
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)